Artificial Intelligence in Oncology Symposium

A dark blue background with DNA and molecules throughout the background. A blue silhouette head is at the forefront of the left of the image with deep learning equations in the background on the right.

Precision Medicine and Cancer Disparities

November 8-9, 2021 | Virtual

Now in its third year, the 2021 Artificial Intelligence in Oncology Symposium: Precision Medicine and Cancer Disparities will bring together clinicians, biomedical engineers, computer scientists, executives, thought leaders, and entrepreneurs with expertise in precision medicine, AI, machine learning, and oncology. These experts will discuss technical advances in AI, the challenges and advancements in deploying AI in the clinic, the need for the use of AI to address health disparities, the current regulatory and reimbursement landscape for AI in medicine, and the potential of AI to impact global health. For the health and safety of all attendees, this year's symposium will again take place virtually.

View the AIO agenda

Register to attend


Call for Abstracts: Now Open! 

All students, postdocs, residents and fellows conducting research in Artificial Intelligence in Oncology are invited to submit abstracts. A committee will review abstracts based on the relationship to cancers and AI, novelty, significance of findings, and clarity.

Deadline: September 24, 2021

Submit an abstract


Presentations from Top Experts across Industries

During this two-day virtual symposium, speakers and panelists will dive into discussions on technical advances in AI, how AI and machine learning are being used as diagnostic and prognostic tools in clinical decision-making, cancer disparities and global health, and the ethics and policy surrounding this ever-changing field.

Keynote Presentation: "AI Enabled Re-Thinking of Microscopy for All-Digital Cancer Pathology"
Headshot of Rohit Bhargava. Man in dark suit.

Rohit Bhargava, PhD
Director, Cancer Center at Illinois
Professor, Bioengineering
University of Illinois Urbana-Champaign

Rohit Bhargava, PhD has pioneered the development of infrared spectroscopic imaging, starting from his doctoral thesis that was the first in this field. Bhargava has developed several new capabilities in IR instrumentation, provided new methods to analyze spectral data, and developed high-throughput methods for pathology. 

Bhargava received his PhD from Case Western Reserve University in 2000 and his undergraduate degree from Indian Institute of Technology, New Delhi, in 1996. In addition to his role as director of the Cancer Center at Illinois, Dr. Bhargava is a professor in the Illinois Department of Bioengineering and is a full-time faculty member in the Beckman Institute Bioimaging Science and Technology Group.

View #AIO2021 Speakers


Network and Connect Virtually

While we wanted to collaborate in person again this year, we are greatly looking forward to connecting through our web-based conference application, Whova, where attendees will not only be able to view presentations, but also ask questions during panel discussions and network behind the scenes. Registered attendees will receive invitations and instructions to access the virtual conference on Monday, October 18.


Virtual Web-Based Experience

Whova logo blue box white text

Attendees will experience the conference using Whova, our official web-based conference app, to view presentations and ask questions during panel discussions, and to easily network and connect behind the scenes. Attendees who register before October 18 will receive conference access information two weeks before the event. Attendees who register after October 18 will receive access information the business day following their registration, or within an hour of registration day-of event.

View Whova Attendee User Guide


 

Sponsors and exhibitors

This event is made possible by the support of our sponsors and exhibitors.

University of Illinois logo

Department of Bioengineering, University of Illinois Urbana-Champaign